1
Views
0
CrossRef citations to date
0
Altmetric
Microbiology

Have South Australian isolates of Neisseria meningitidis become less susceptible to penicillin, rifampicin and other drugs? A study of strains isolated over three decades, 1971–1999

, , &
Pages 160-165 | Received 02 Jul 2003, Accepted 04 Dec 2003, Published online: 06 Jul 2009

References

  • Turner PC, Southern KW, Spencer NJB, et al. Treatment failure in meningococcal meningitis. Lancet 1990; 335: 732–3.
  • Galimand M, Gerbaud G, Guibourdenche M, et al. High-level chloramphenicol resistance in Neisseria meningitidis. New Engl J Med 1998; 339: 868–74.
  • Hansman D, Ashton F. Serotype and serosubtype distribution of strains of Neisseria meningitidis isolated in South Australia and the Northern Territory of Australia: 1971-1989. Pathology 1994; 26: 318–20.
  • NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. NCCLS docu-ment M7-A4. Wayne, PA: National Committee for Clinical Laboratory Standards, 1999.
  • E test AB Biodisk recommendations. Solna Sweden: AB Biodisk, 2003.
  • Leedom JM, Tyler D, Mathies AW, et al. Importance of sulfadiazine resistance in meningococcal disease in civilians. New Engl J Med 1965; 273: 1395–401.
  • Abbott JD, Adams D, Collins Ti. Sensitivity of meningococci to sodium sulphadiazine and six antibiotics. J Med Microbiol 1970; 3: 233–41.
  • Comité de l'Antibiogramme de la Societe Française de Microbiologie [CA SFM] report 2001. http:/www.sfm.asso.fr/. Accessed January 2004.
  • Hughes JH, Biedenbach DJ, Erwin ME, et al. E test as susceptibility test and epidemiologic tool for evaluation of Neisseria meningitidis isolates. J Clin Microbiol 1993; 31: 3255–9.
  • Marshall SA, Rhomberg PR, Jones RN. Comparative evaluation of E test for susceptibility testing Neisseria meningitidis with eight antimicrobial agents. Diagn Microbiol Infect Dis 1997; 27: 93–7.
  • Millar JW, Siess EE, Feldman HA, et al. In vivo and in vitro resistance to sulfadiazine in strains of Neisseria meningitidis. JAMA 1963; 186: 139–41.
  • Feldman HA. Sulfonamide-resistant meningococci. Annu Rev Med 1967; 18: 495–506.
  • Enne VI, Livermore DM, Stephens P, et al. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 2001; 357: 1325–8.
  • Naraqi S, Kirkpatrick GP, Kabins S. Relapsing pneumococcal meningitis: isolation of an organism with decreased susceptibility to penicillin G. J Pediatr 1974; 85: 671–3.
  • Howes Vi, Mitchell RG. Meningitis due to relatively penicillin-resistant pneumococcus. Br Med J 1976; 1: 996.
  • Annual report of the Australian meningococcal surveillance programme, 2002. Communicable Diseases Intelligence 2003; 27: 196–208.
  • Hansman D, Glasgow H, Sturt J, et al. Increased resistance to penicillin of pneumococci isolated from man. New Engl J Med 1971; 284: 175–7.
  • Cooper ER, Ellison RT III, Smith GS, et al. Rifampicin-resistant meningococcal disease in a contact patient given prophylactic rifampicin. J Pediatr 1986; 108: 93–6.
  • Yagupsky P, Ashkenazi S, Block C. Rifampicin-resistant meningo-cocci causing invasive disease and failure of chemoprophylaxis. Lancet 1993; 341: 1152–3.
  • Guttler RB, Beaty HN. Minocycline in the chemoprophylaxis of meningococcal disease. Antimicrob Agents Chemother 1972; 1: 397–402.
  • Gaunt PN, Lambert BE. Single dose ciprofloxacin for the eradication of pharyngeal carriage of Neisseria meningitidis. J Antimicrob Che-mother 1988; 21: 489–96.
  • Schwartz B, Al-Tobaiqi A, Al-Ruwais A, et al. Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis. Lancet 1988; 1: 1239–42.
  • Wall RA. The chemoprophylaxis of meningococcal infection. J Antimicrob Chemother 1988; 21: 698–700.
  • Girgis N, Sultan Y, Frenck RW Jr, et al. Azithromycin compared with rifampicin for eradication of nasopharyngeal colonisation by Neisseria meningitidis. Pediatr Infect Dis J 1998; 17: 816–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.